Weight-loss drug developers line up to tap lucrative market as competition heats up
Biotech and pharma giants including Novo Nordisk, Eli Lilly and Pfizer race to develop next-generation weight-loss pills and injections as the obesity drug market heads toward $100 billion in annual sales
Reuters6 min read
Share

(Photo by Towfiqu barbhuiya on Unsplash)
Add Emirates 24|7 to your Google News
Text Size:
